Home > Products > CD3 & PD1
> Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (scFv-CH3)
Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (scFv-CH3) (CAT#: BSFC-098)
Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (scFv-CH3) contains two chains. The anti-CD3 scFv is fused to the Knob-CH3 domain via a hinge region and the same as the anti-PD1 scFv to the Hole-CH3 domain, or vice versa. The KIH CH3 domains can facilitate to form a heterodimer and this bivalent binding leads to improvement in avidity. This BsAb can retarget T cells to tumor cells. It is designed for the research of Esophageal cancer; Hodgkin lymphoma; Renal cell cancer (RCC); Mesothelioma; Head and neck squamous cell cancer (HNSCC); Anal cancer; Gastric cancer; Hepatocellular cancer; Nasopharyngeal cancer; Non-small cell lung cancer (NSCLC); Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (scFv-CH3) (BSFC-098). Click the button below to contact us or submit your feedback about this product.